cytochrome P450 CYP2D6
Selected indexed studies
- Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. (Clin Pharmacol Ther, 2023) [PMID:37313955]
- Potential cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments. (Crit Rev Oncol Hematol, 2021) [PMID:33930533]
- Cytochrome P450: genotype to phenotype. (Xenobiotica, 2020) [PMID:31411087]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Impact of Viloxazine Extended-Release Capsules (Qelbree(®)) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. (2024) pubmed
- Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. (2023) pubmed
- Cytochrome P450 inhibition activities of non-standardized botanical products. (2022) pubmed
- Cytochrome P450: genotype to phenotype. (2020) pubmed
- Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. (2015) pubmed
- Pharmacogenetics and psychopharmacotherapy. (2000) pubmed
- Potential cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments. (2021) pubmed
- The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine. (2001) pubmed
- Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers. (2024) pubmed
- Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients. (2020) pubmed